Cooperative Agreement HT94252320045
Award Date
9/15/23
Completion Date
9/14/33
Dollars Obligated
$6.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Cooperative Agreement
Place of Performance
Thailand
Similar Awards
This Cooperative Agreement award of $638,820 from the Defense Health Agency supports an mRNA multivalent approach to develop an innovative malaria vaccine. The project, funded through the Military Medical Research and Development program (CFDA 12.420), aims to broaden the immune targets against malaria infection by including both pre-erythrocytic-stage antigens and mosquito saliva antigens. The Geneva Foundation, a non-profit research organization, will conduct this research over a 3-year period...
This Cooperative Agreement, awarded by the Defense Health Agency, provides $568,275 in funding to Conserv Bioscience LIMITED, a foreign-owned for-profit organization, to develop an mRNA multivalent approach including pre-erythrocytic-stage antigens and mosquito saliva antigens to broaden the immune targets against malaria infection. The funding is provided through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical...
This Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program provides $305,352.20 to Population Services International (PSI) to implement the "GUATEMALA, EL SALVADOR, AND HONDURAS: DHAPP CENTRAL AMERICAN ARMED FORCES PARTNERSHIP FOR SUSTAINABLE HIP EPIDEMIC CONTROL" project. The funding will support HIV/AIDS and gender-based violence prevention programs targeting military schools in these Central...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,857,470 Cooperative Agreement to The Geneva Foundation to develop a multiplex testing platform that can simultaneously detect and identify Plasmodium species infections. This platform will serve as both a diagnostic tool and an epidemiological surveillance tool. The project performance period is from June 1, 2024 to May 31, 2028. Under a $268,312 sub-award, Meso Scale...
This Project Grant award of $10,606,583.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports advanced biomedical research to transform healthcare for military service members and the broader public. The award will fund research to improve the radical cure of malaria through a combination of the antimalarial drug tafenoquine and a novel ATP4 inhibitor called SJ733. The University of Kentucky Research Foundation, a...
This $260,109 cooperative agreement from the Uniformed Services University of the Health Sciences will support surveillance for Rift Valley fever, rickettsia, malaria, dengue, chikungunya, and Crimean-Congo hemorrhagic fever disease pathogens. The Henry M. Jackson Foundation for the Advancement of Military Medicine will collect human samples and arthropod vectors from selected sites in Botswana to test for these pathogens. Under a subaward, Virginia Polytechnic Institute and State University...
The Project Grant award for $897,448.00, awarded on June 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports Oregon Health & Science University's development of "NEXT-GENERATION ELQS FOR LONG-TERM PROTECTION AGAINST MALARIA." This research initiative aims to advance novel treatments and protective measures against malaria, a key focus area for the Defense Health Agency's military medical research initiatives....
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $702,204 Cooperative Agreement under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the London School of Hygiene and Tropical Medicine (LSHTM) to conduct research on complex malaria in India. The key products and services to be delivered through this 5-year project include: Monitoring the changing epidemiology of malaria in Odisha, India through a 4-year community-based cohort study to...
Metabiota, Inc. was awarded a $3.5 million cooperative agreement from the Defense Health Agency under the Department of Defense HIV/AIDS Prevention Program (CFDA 12.350) for the period of October 1, 2021 through September 30, 2023. The award will support Metabiota's efforts to build HIV epidemic control in Cameroon through strengthening HIV prevention, testing, linkage to care and treatment, and viral suppression programs within the Cameroon Defense Force. As part of this cooperative...
This Federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $504,678 in funding to the Mountain Home Research & Education Corporation for a research project titled "LONG NONCODING RNAS IN VIRAL LYMPHOMAS". The award period runs from September 30, 2023 to September 29, 2025. The project aims to conduct basic, translational, and clinical research related to military medicine, with a focus on...